IFRXNasdaqPharmaceutical PreparationsFiscal year ends December 31
InflaRx N.V.
Financials through fiscal 2025, year ended Dec 31, 2025Last filing: 20-F on Mar 20, 2026
$1.45+0.13 (+9.85%)
Close on Oct 19, 2026
InflaRx statistics
Financials through Dec 31, 2025, price-based ratios appear once a share price is available, median of Pharmaceutical Preparations companies for comparison
Valuation
| Measure | InflaRx | Industry median |
|---|---|---|
| Market Cap | €93.65M | €878.09M |
| Enterprise Value | €77.63M | €706.41M |
| PS Ratio | 3192.93 | 6.85 |
| PB Ratio | 13.06 | 0.94 |
| P/TBV Ratio | 13.06 | 1.22 |
Enterprise value
| Measure | InflaRx | Industry median |
|---|---|---|
| EV / Sales | 2646.68 | 3.86 |
Income (trailing twelve months)
| Measure | InflaRx | Industry median |
|---|---|---|
| Revenue | €29.33K | €465.66M |
| Gross Profit | -€7.24M | €1.08B |
| Pretax Income | -€45.62M | -€47.40M |
| EPS (Diluted) | -0.68 EUR | -0.55 EUR |
Margins
| Measure | InflaRx | Industry median |
|---|---|---|
| Gross Margin | -24677.9% | 42.5% |
| Pretax Margin | -155540.0% | -36.6% |
Growth
| Measure | InflaRx | Industry median |
|---|---|---|
| Revenue Growth (YoY) | -82.3% | -1.08% |
Balance sheet
| Measure | InflaRx | Industry median |
|---|---|---|
| Cash & Short-Term Investments | €16.02M | €199.29M |
| Net Cash (Debt) | €16.02M | €111.50M |
| Net Cash Per Share | 0.22 EUR | 1.53 EUR |
| Equity (Book Value) | €7.17M | €472.30M |
| Book Value Per Share | 0.10 EUR | 6.00 EUR |
| Tangible Book Value | €7.17M | €50.66M |
| Working Capital | €40.65M | €119.55M |
Financial position
| Measure | InflaRx | Industry median |
|---|---|---|
| Current Ratio | 4.13 | 3.49 |
| Quick Ratio | 1.23 | 1.51 |
Cash flow (trailing twelve months)
| Measure | InflaRx | Industry median |
|---|---|---|
| Operating Cash Flow | -€35.31M | -€42.16M |
Efficiency
| Measure | InflaRx | Industry median |
|---|---|---|
| Asset Turnover | 0.00 | 0.31 |
| Inventory Turnover | 1.05 | 1.36 |
Dividends and yields
| Measure | InflaRx | Industry median |
|---|---|---|
| Buyback Yield | -24.5% | -11.4% |
| Shareholder Yield | -24.5% | -11.4% |
Shares
| Measure | InflaRx | Industry median |
|---|---|---|
| Shares Outstanding | 72,292,900 | 99,540,150 |
| Shares Change (YoY) | 14.2% | 5.61% |
| Float | 67,948,200 | 78,574,400 |
| Shares Held by Insiders | 6.01% | 9.05% |
Taxes
| Measure | InflaRx | Industry median |
|---|---|---|
| Income Tax | €12.28K | €80.00K |
Scores
| Measure | InflaRx | Industry median |
|---|---|---|
| Altman Z-Score | -4.58 | 1.13 |
Calculated by StockData from InflaRx's SEC filings. Hover a measure to see its formula. The grey column is the median of companies in the same industry group (two-digit SIC code); green or red marks a better or worse value than that median.